Intelligent Bio Solutions Inc.
INBS
NASDAQ·Healthcare·Medical - Devices·Mkt cap $1.4M
$2.23
▼ -3.04%
P/E
—
Mkt Cap
$1.4M
52-Wk Range
$1.52–$24.90
52-Week Range
$1.52 - $24.90
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 86.4% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Non-invasive saliva-based testing technology reducing patient discomfort
- Proprietary organic thin-film transistor (OTFT) biosensor platform
- Real-time monitoring capabilities enabling immediate health insights
- Diversified diagnostic modalities across multiple disease states
Bear Case
1 risk
- Very high volatility (beta 4.2). Expect 3x market swings. Position size accordingly.
Growth
Strong growth ahead
Rising global diabetes prevalence and demand for convenient management solutions
Value
Valuation data unavailable
Momentum
Weak
-7.1% over 3m
Quality
Stable
Solid business
Dividend
None
No dividend
Smart-money signal
Who's buying INBS right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 5, 2026
AUG 19, 2026
Reported EPS of -$1.34 vs -$1.58 consensus (+15.2% surprise). Revenue of $1.2M vs $1.2M expected (0.0%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+15.2%
Revenue trend · last 8Q
—
—
—
-12%
+16%
+27%
+48%
+36%
Q4 24
Q1 24
Q2 24
Q3 25
Q4 25
Q1 25
Q2 25
Q4 26
$727.8K
$872.3K
$607.5K
$728.9K
$843.9K
$1.1M
$896.8K
$1.1M
Margins · last 8Q
Gross
46.8%
Profit
-341.0%
Wall Street consensus
Analyst coverage
Live ratings and price targets aggregated across covering analysts.
vs Industry
How INBS stacks vs Medical - Devices
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related